Analysts Set Astera Labs, Inc. (NASDAQ:ALAB) Target Price at $202.22

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have been given a consensus rating of “Moderate Buy” by the twenty-two analysts that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and fifteen have assigned a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $202.2222.

Several brokerages have recently commented on ALAB. Royal Bank Of Canada began coverage on Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price on the stock. Raymond James Financial began coverage on Astera Labs in a report on Friday, November 21st. They set a “hold” rating for the company. Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective for the company. Barclays set a $165.00 price objective on Astera Labs in a research note on Thursday, January 15th. Finally, Citigroup lowered their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th.

Astera Labs Stock Down 8.0%

Shares of ALAB stock opened at $116.04 on Monday. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The company has a market capitalization of $19.75 billion, a P/E ratio of 95.11, a P/E/G ratio of 2.48 and a beta of 1.74. The firm has a 50-day moving average price of $144.10 and a 200 day moving average price of $166.18.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the sale, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This represents a 5.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel owned 128,084 shares of the company’s stock, valued at $15,046,027.48. The trade was a 7.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 384,292 shares of company stock worth $48,724,919 over the last quarter. Corporate insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Several hedge funds have recently modified their holdings of the stock. Hsbc Holdings PLC increased its holdings in shares of Astera Labs by 128.5% in the fourth quarter. Hsbc Holdings PLC now owns 83,721 shares of the company’s stock valued at $14,126,000 after purchasing an additional 47,081 shares in the last quarter. Spear Advisors LLC acquired a new position in Astera Labs during the 4th quarter worth $15,787,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in Astera Labs in the 4th quarter valued at $75,000. Bank of Hawaii increased its stake in shares of Astera Labs by 12.7% in the 4th quarter. Bank of Hawaii now owns 28,580 shares of the company’s stock valued at $4,755,000 after buying an additional 3,221 shares during the period. Finally, Reflection Asset Management acquired a new stake in shares of Astera Labs in the 4th quarter valued at $25,000. 60.47% of the stock is owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.